Gene · 773
Papers4,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Redefining the Pathogenic CAG Repeat Units Threshold in CACNA1A for Spinocerebellar Ataxia Type 6. | Neurol Genet | 2025 | 39996131 | PubTator, text mining | PubMed |
| Resilience to Endoplasmic Reticulum Stress Mitigates Calcium-Dependent Membrane Hyperexcitability Underlying Late Disease Onset in SCA6. | bioRxiv | 2025 | 39975408 | PubTator, text mining | PubMed |
| Psychoses of Epilepsy: Unravelling the Phenotypic and Genotypic Features. | Ann Neurol | 2025 | 39950246 | PubTator, text mining | PubMed |
| A novel signature of cartilage aging-related immunophenotyping biomarkers in osteoarthritis. | Comput Biol Med | 2025 | 39938337 | PubTator, text mining | PubMed |
| Susceptibility to pseudoexfoliation linked to intronic variant rs4926246 in CACNA1A: Evidence from an Indian population study. | Biochim Biophys Acta Gene Regul Mech | 2025 | 39826673 | PubTator, text mining | PubMed |
| Diagnosis of hereditary ataxias: a real-world single center experience. | J Neurol | 2025 | 39812846 | PubTator, text mining | PubMed |
| Exploring the association between familial hemiplegic migraine genes (CACNA1A, ATP1A2 and SCN1A) with migraine and epilepsy: A UK Biobank exome-wide association study. | Cephalalgia | 2025 | 39781574 | PubTator, text mining | PubMed |
| N-Acetyl-leucine in progressive CACNA1A ataxia: A case series. | Eur J Paediatr Neurol | 2025 | 39765122 | PubTator, text mining | PubMed |
| A Longitudinal Exploration of CACNA1A-Related Hemiplegic Migraine in Children Using Electronic Medical Records. | Neurol Genet | 2025 | 39763636 | PubTator, text mining | PubMed |
| Association between CACNA1A and ATP1A2 Variants are Responsible for Severe Neurodevelopmental Disorder. | Neuropediatrics | 2025 | 39667411 | PubTator, text mining | PubMed |
| In vitro human ion channel assays predictive of drug-induced seizure. | Toxicol Sci | 2025 | 39661496 | PubTator, text mining | PubMed |
| Exome sequencing in Nigerian children with early-onset epilepsy syndromes. | Epilepsia Open | 2025 | 39570184 | PubTator, text mining | PubMed |
| Inherited Spinocerebellar Ataxia Segregates with Intra-Familial Genetic Heterogeneity in a Consanguineous Pakistani Family: A Report of a Potential Novel Candidate Gene. | DNA Cell Biol | 2025 | 39506885 | PubTator, text mining | PubMed |
| CACNA1A haploinsufficiency leads to reduced synaptic function and increased intrinsic excitability. | Brain | 2025 | 39460936 | PubTator, text mining | PubMed |
| The clinical and genetic spectrum of paediatric speech and language disorders. | Brain | 2025 | 39412438 | PubTator, text mining | PubMed |
| Efficacy of galcanezumab in proline-rich transmembrane protein 2 (PRRT2)-associated familial hemiplegic migraine: A case series. | Headache | 2025 | 39345003 | PubTator, text mining | PubMed |
| A biallelic mutation in CACNA2D2 associated with developmental and epileptic encephalopathy affects calcium channel-dependent as well as synaptic functions of α2δ-2. | J Neurochem | 2025 | 39161180 | PubTator, text mining | PubMed |
| Autism-Linked Mutations in α2δ-1 and α2δ-3 Reduce Protein Membrane Expression but Affect Neither Calcium Channels nor Trans-Synaptic Signaling. | Pharmaceuticals (Basel) | 2024 | 39770450 | PubTator, text mining | PubMed |
| Pin1 promotes human CaV2.1 channel polyubiquitination by RNF138: pathophysiological implication for episodic ataxia type 2. | Cell Commun Signal | 2024 | 39609819 | PubTator, text mining | PubMed |
| A structural analysis of the splice-specific functional impact of the pathogenic familial hemiplegic migraine type 1 S218L mutation on Cav2.1 P/Q-type channel gating. | Mol Brain | 2024 | 39568055 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/773/papers?page=9